Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment

被引:12
|
作者
Reiner, Benjamin C. [1 ]
Crist, Richard C. [1 ]
Borner, Tito [1 ,2 ]
Doyle, Robert P. [3 ]
Hayes, Matthew R. [1 ,2 ]
De Jonghe, Bart C. [1 ,2 ]
机构
[1] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Biobehav Hlth Sci, Philadelphia, PA 19104 USA
[3] Syracuse Univ, Dept Chem, 111 Coll Pl, Syracuse, NY 13244 USA
来源
MOLECULAR METABOLISM | 2022年 / 56卷
关键词
Area postrema; Nucleus of the solitary tract; GDF15; GFRAL; RET; MACROPHAGE INHIBITORY CYTOKINE-1; WEIGHT-LOSS; RECEPTOR; BRAIN; CACHEXIA; PATHWAY; OBESITY; MARKER; NAUSEA; MICE;
D O I
10.1016/j.molmet.2021.101422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Growth differentiation factor 15 (GDF15) is known to play a role in feeding, nausea, and body weight, with action through the GFRAL-RET receptor complex in the area postrema (AP) and nucleus tractus solitarius (NTS). To further elucidate the underlying cell type-specific molecular mechanisms downstream of GDF15 signaling, we used a single nuclei RNA sequencing (snRNAseq) approach to profile AP and NTS cellular subtype-specific transcriptomes after systemic GDF15 treatment. Methods: AP and NTS micropunches were used for snRNAseq from Sprague Dawley rats 6 h following GDF15 or saline injection, and Seurat was used to identify cellular subtypes and cell type-specific alterations in gene expression that were due to the direct and secondary effects of systemic GDF15 treatment. Results: Using the transcriptome profile of similar to 35,000 individual AP/NTS nuclei, we identified 19 transcriptomically distinct cellular subtypes, including a single population Gfral and Ret positive excitatory neurons, representing the primary site of action for GDF15. A total of similar to 600 cell type-specific differential expression events were identified in neurons and glia, including the identification of transcriptome alterations specific to the direct effects of GDF15 in the Gfral-Ret positive excitatory neurons and shared transcriptome alterations across neuronal and glial cell types. Downstream analyses identified shared and cell type-specific alterations in signaling pathways and upstream regulatory mechanisms of the observed transcriptome alterations. Conclusions: These data provide a considerable advance in our understanding of AP and NTS cell type-specific molecular mechanisms associated with GDF15 signaling. The identified cellular subtype-specific regulatory mechanism and signaling pathways likely represent important targets for future pharmacotherapies. (C) 2021 The Author(s). Published by Elsevier GmbH.
引用
收藏
页数:8
相关论文
共 24 条
  • [1] GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS
    Tsai, Vicky Wang-Wei
    Zhang, Hong Ping
    Manandhar, Rakesh
    Schofield, Peter
    Christ, Daniel
    Lee-Ng, Ka Ki Michelle
    Lebhar, Helene
    Marquis, Christopher Peter
    Husaini, Yasmin
    Brown, David A.
    Breit, Samuel N.
    INTERNATIONAL JOURNAL OF OBESITY, 2019, 43 (12) : 2370 - 2380
  • [2] Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges
    Zhang, Jincheng
    Sun, Jingquan
    Li, Jielang
    Xia, Hongwei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (24)
  • [3] Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum
    Fejzo, Marlena S.
    MacGibbon, Kimber W.
    First, Olivia
    Quan, Courtney
    Mullin, Patrick M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (11) : 1845 - 1852
  • [4] Knocking on GDF15?s door for the treatment of type 2 diabetes mellitus
    Aguilar-Recarte, David
    Barroso, Emma
    Palomer, Xavier
    Wahli, Walter
    Vazquez-Carrera, Manuel
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2022, 33 (11) : 741 - 754
  • [5] Neutralizing antibody against GDF15 for treatment of cancer-associated cachexia
    Xiong, Junyi
    Wu, Guojin
    Ning, Jinying
    Yan, Junlin
    Yang, Jian
    Kang, Jinsen
    PLOS ONE, 2024, 19 (08):
  • [6] Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury
    Liu, Jing
    Kumar, Sanjeev
    Heinzel, Andreas
    Gao, Michael
    Guo, Jinjin
    Alvarado, Gregory F.
    Reindl-Schwaighofer, Roman
    Krautzberger, A. Michaela
    Cippa, Pietro E.
    McMahon, Jill
    Oberbauer, Rainer
    McMahon, Andrew P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (04): : 701 - 715
  • [7] Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment
    Diaz, Marta
    Carreras-Badosa, Gemma
    Villarroya, Joan
    Gavalda-Navarro, Aleix
    Bassols, Judit
    de Zegher, Francis
    Lopez-Bermejo, Abel
    Villarroya, Francesc
    Ibanez, Lourdes
    PEDIATRIC RESEARCH, 2023, 93 (04) : 964 - 968
  • [8] Treatment with GDF15, a TGFβ superfamily protein, induces protective effect on retinal ganglion cells
    Iwata, Yuki
    Inagaki, Satoshi
    Morozumi, Wataru
    Nakamura, Shinsuke
    Hara, Hideaki
    Shimazawa, Masamitsu
    EXPERIMENTAL EYE RESEARCH, 2021, 202
  • [9] Daily GDF15 treatment has sex-specific effects on body weight and food intake and does not enhance the effects of voluntary physical activity in mice
    Jeromson, Stewart
    Akcan, Michael
    Baranowski, Bradley
    Arbeau, Meagan
    Bellucci, Annalaura
    Wright, David C.
    JOURNAL OF PHYSIOLOGY-LONDON, 2024, : 6813 - 6826
  • [10] Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
    Albuquerque, Bina
    Chen, Xian
    Hirenallur-Shanthappa, Dinesh
    Zhao, Yang
    Stansfield, John C.
    Zhang, Bei B.
    Sheikh, Abdul
    Wu, Zhidan
    CELLS, 2022, 11 (07)